Rep profile
Rep profile
Murrell Bollinger
company
3M Pharmaceuticals
Title
Professional sales representative
current home
Winchester, VA
Territory: Shenandoah Valley region.
Customers: OB/GYNs, cardiologists, primary care physicians and internal medicine.
Awards: Bronze and silver awards; Sales rep of the year 1994, 1995 and 1996; Honors Circle member.
Sales techniques: "I find a common interest between the physician and myself. This separates me from other reps and makes the physicians more receptive to me. I don't try to get the physician to write a lot of prescriptions at once. I am confident in the products I sell and believe that if I can get the physician to write at least one prescription, he or she will want to use the product again."
Sales Philosophy: "I believe a rep needs to be honest to earn the respect of a physician."
Motivation: "I have a strong desire to compete and to win. I don't get discouraged. If someone tells me something is too difficult or can't be done, that gives me incentive to try even harder."
Interest in industry: "After I graduated from college, a friend who was a pharmacist told me about pharmaceutical sales. I talked with someone in the field and knew that I had found my niche."
Industry change: "The pharmaceutical industry has changed a lot. Reps today must be technically oriented. They must stay on top of changes and new processes in the pharmaceutical industry. There are also more specialists today. Representatives need to keep on top of research in order to sell to physicians who concentrate in one area of medicine."
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Asembia 2025: Therapy Advancements Highlight Growing Cost and Access Concerns
April 30th 2025Fran Gregory, VP, emerging therapies, Cardinal Health, discusses the evolving cell and gene therapy landscape, highlighting pipeline growth, cost challenges, and emerging therapeutic areas beyond oncology and hematology.